GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
$5.45
+5.11 (+1,494.50%)
At Close: Apr 22, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.265 $5.95 Monday, 22nd Apr 2024 WINT stock ended at $5.45. This is 1,494.50% more than the trading day before Friday, 19th Apr 2024. During the day the stock fluctuated 21.18% from a day low at $4.91 to a day high of $5.95.
90 days $0.265 $5.95
52 weeks $0.265 $5.95

Historical Windtree Therapeutics Inc prices

Date Open High Low Close Volume
Apr 22, 2024 $4.91 $5.95 $4.91 $5.45 193 048
Apr 19, 2024 $0.350 $0.360 $0.330 $0.342 470 528
Apr 18, 2024 $0.395 $0.400 $0.265 $0.340 1 788 291
Apr 17, 2024 $0.419 $0.419 $0.369 $0.401 105 182
Apr 16, 2024 $0.430 $0.430 $0.405 $0.422 109 794
Apr 15, 2024 $0.422 $0.435 $0.405 $0.424 103 613
Apr 12, 2024 $0.386 $0.480 $0.360 $0.435 771 087
Apr 11, 2024 $0.360 $0.390 $0.355 $0.379 70 088
Apr 10, 2024 $0.373 $0.390 $0.351 $0.380 40 192
Apr 09, 2024 $0.402 $0.413 $0.361 $0.371 340 892
Apr 08, 2024 $0.430 $0.431 $0.397 $0.410 137 930
Apr 05, 2024 $0.384 $0.429 $0.384 $0.424 168 865
Apr 04, 2024 $0.377 $0.384 $0.360 $0.384 56 751
Apr 03, 2024 $0.350 $0.380 $0.340 $0.380 144 861
Apr 02, 2024 $0.369 $0.369 $0.350 $0.368 45 809
Apr 01, 2024 $0.343 $0.368 $0.343 $0.366 25 625
Mar 28, 2024 $0.360 $0.368 $0.350 $0.354 28 479
Mar 27, 2024 $0.355 $0.368 $0.340 $0.368 45 038
Mar 26, 2024 $0.360 $0.360 $0.353 $0.354 38 295
Mar 25, 2024 $0.360 $0.360 $0.352 $0.360 9 844
Mar 22, 2024 $0.360 $0.360 $0.355 $0.360 18 249
Mar 21, 2024 $0.366 $0.370 $0.350 $0.355 51 696
Mar 20, 2024 $0.355 $0.360 $0.350 $0.355 25 675
Mar 19, 2024 $0.347 $0.370 $0.340 $0.350 99 475
Mar 18, 2024 $0.340 $0.365 $0.340 $0.341 51 532
Click to get the best stock tips daily for free!

About Windtree Therapeutics Inc

Windtree Therapeutics Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF,... WINT Profile

Golden Star

Ticker Date Change Price
FTSL Apr 18 0.130% $46.22
LNG Apr 17 2.33% $156.81
FCN Apr 16 1.98% $207.62
ELV Apr 16 4.98% $506.97
AKR Apr 05 5.38% $16.53
ITCI Apr 05 8.91% $68.44
SARK Mar 28 17.19% $26.88
ARCC Mar 25 2.68% $20.12
CCK Mar 20 2.77% $77.29
STT Mar 19 2.60% $72.62
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT